METHODS OF TREATING CANCER HAVING AN ABERRANT EGFR OR KRAS GENOTYPE
- 专利权人:
- Shengfang Jin
- 发明人:
- Shengfang Jin,Shinsan Su,Matthew Van Der Heiden
- 申请号：
- US13249609
- 公开号：
- US20120041070A1
- 申请日:
- 2011.09.30
- 申请国别(地区):
- US
- 年份:
- 2012
- 代理人:
- 摘要：
- The invention relates to the treating cancer having an aberrant EGFR or KRAS genotype, with an AMPK activator, as well as related methods, compounds and compositions.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- NOVEL TRICYCLIC PROTEIN KINASE MODULATORS
- COMPOUNDS AND COMPOSITIONS FOR MODULATING EGFR MUTANT KINASE ACTIVITIES
- Peptide inhibitors of protein kinase C
- COMPOUNDS AND METHODS FOR MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION
- COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
